146 related articles for article (PubMed ID: 18234303)
1. Evidence-based chemotherapy administration in advanced ovarian cancer: an impressive past, a disquieting present and an uncertain future.
Markman M
Gynecol Oncol; 2008 Apr; 109(1):4-7. PubMed ID: 18234303
[No Abstract] [Full Text] [Related]
2. [Intraperitoneal chemotherapy for ovarian cancer].
Noma J; Yoshida N
Gan To Kagaku Ryoho; 2008 Jun; 35(6):885-90. PubMed ID: 18633214
[TBL] [Abstract][Full Text] [Related]
3. The management of ovarian carcinoma.
Kehoe S
Minerva Ginecol; 2008 Apr; 60(2):155-64. PubMed ID: 18487966
[TBL] [Abstract][Full Text] [Related]
4. Low-dose metronomic chemotherapy: myth or truth?
Baruchel S; Stempak D
Onkologie; 2006 Jul; 29(7):305-7. PubMed ID: 16874013
[No Abstract] [Full Text] [Related]
5. Chemotherapy of advanced ovarian cancer.
Casey MJ
Conn Med; 1974 Jan; 38(1):1-3. PubMed ID: 4813666
[No Abstract] [Full Text] [Related]
6. Intraperitoneal chemotherapy for women with epithelial ovarian cancer.
Trimble EL; Thompson S; Christian MC; Minasian L
Oncologist; 2008 Apr; 13(4):403-9. PubMed ID: 18448554
[TBL] [Abstract][Full Text] [Related]
7. The promise and perils of 'targeted therapy' of advanced ovarian cancer.
Markman M
Oncology; 2008; 74(1-2):1-6. PubMed ID: 18536523
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy administration for ovarian cancer by gynecologic oncologists and medical oncologists.
Berchuck A
J Clin Oncol; 2007 Aug; 25(23):3552; author reply 3557-8. PubMed ID: 17687164
[No Abstract] [Full Text] [Related]
9. Intraperitoneal chemotherapy: standard of care for patients with minimal residual stage III ovarian cancer?
Tummala MK; Alagarsamy S; McGuire WP
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1135-47. PubMed ID: 18588458
[TBL] [Abstract][Full Text] [Related]
10. Haematological evaluation of weekly therapy with topotecan for the treatment of recurrent ovarian cancer resistant to platinum-based therapy.
Largillier R; Valenza B; Ferrero JM; Novo C; Creisson A; Lesbats G; Mari V; Hebert C; Chamorey E
Oncology; 2007; 73(3-4):177-84. PubMed ID: 18418010
[TBL] [Abstract][Full Text] [Related]
11. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
Ozols RF
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal chemotherapy in ovarian cancer: an update.
Runowicz CD
Cancer J; 2008; 14(1):7-9. PubMed ID: 18303475
[TBL] [Abstract][Full Text] [Related]
13. [Results obtained with directed chemotherapy of ovarian cancer (author's transl)].
Dvorák O
Cesk Gynekol; 1976 Dec; 41(10):717-8. PubMed ID: 1009601
[No Abstract] [Full Text] [Related]
14. A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer.
Markman M
Gynecol Oncol; 2009 Jul; 114(1):136-7; authore reply 137. PubMed ID: 19138792
[No Abstract] [Full Text] [Related]
15. Ovarian cancer: is dose intensity dead?
Ozols RF
J Clin Oncol; 2007 Sep; 25(27):4157-8. PubMed ID: 17698802
[No Abstract] [Full Text] [Related]
16. [New developments in the chemotherapy of ovarian cancer (author's transl)].
Brunner KW; Goldhirsch A; Joss R
Schweiz Rundsch Med Prax; 1981 Apr; 70(18):809-14. PubMed ID: 7243721
[No Abstract] [Full Text] [Related]
17. Optimizing management of recurrent epithelial ovarian cancer: a critical need for evidence-based data.
Markman M
Oncology; 2006; 71(5-6):309-11. PubMed ID: 17873498
[No Abstract] [Full Text] [Related]
18. The search for optimal chemotherapy for advanced epithelial ovarian cancer.
Harrington KJ; Lambert HE
Clin Oncol (R Coll Radiol); 1995; 7(6):359-65. PubMed ID: 8590696
[No Abstract] [Full Text] [Related]
19. Dose-intense chemotherapy in cancer management.
Gonzalez MF; Carr DS
J S C Med Assoc; 1990 May; 86(5):307-10. PubMed ID: 2342338
[No Abstract] [Full Text] [Related]
20. Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
Naumann RW; Sukumvanich P; Edwards RP
Gynecol Oncol; 2009 Jul; 114(1):37-41. PubMed ID: 19410281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
